In the past decade, therapeutic hypothermia using a variety of low-cost devices has been
widely implemented in India and other low-and middle-income countries (LMIC) without …

Aim To examine the incidence of intrapartum-related neonatal encephalopathy, and
neonatal mortality and neurodevelopmental outcomes associated with it in low-income and …

Hypoxic ischaemic encephalopathy (HIE) is a major cause of neonatal mortality and
disability in the United Kingdom (UK) and has significant human and financial costs …

Objective To evaluate the neuroprotective effect of therapeutic hypothermia (TH) induced by
phase changing material (PCM) on MRI biomarkers in infants with hypoxic-ischaemic …

Objective To assess the effect of therapeutic hypothermia on the outcome in term neonates
with hypoxic ischemic encephalopathy (HIE). Methods A randomized controlled trial was …

Objective To determine the effectiveness of phase-change-material mattress (PCM) during
transportation of newborns with hypoxic ischemic encephalopathy (HIE). Study design …

Although therapeutic hypothermia (TH) is the standard of care for hypoxic ischaemic
encephalopathy in high-income countries, the safety and efficacy of this therapy in low …

Objective To evaluate whether magnesium sulfate and therapeutic hypothermia in
combination decreases mortality and/or major neurodevelopmental disability at 1 y of age …

Objective To assess whether serum levels of neuronal biomarkers (S100 calcium-binding
protein B and Neuron specific enolase) correlate with the neurodevelopmental outcome of …

(1) Background: The field of medicine requires simple cooling materials. However, there is
little knowledge documented about phase change materials (PCM) covering the range of 28 …